Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …

Background Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin
receptor blockers (ARBs) are widely prescribed for primary hypertension (systolic blood …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …

Background ACE inhibitors are widely prescribed for hypertension so it is essential to
determine and compare their effects on blood pressure (BP), heart rate and withdrawals due …

Some evidence suggests that long-term angiotensin-converting enzyme (ACE) inhibition
may become less effective, thereby increasing angiotensin II levels, which could be inhibited …

Aims Renin–angiotensin–aldosterone system (RAAS) inhibitors are well established for the
reduction in cardiovascular morbidity, but their impact on all-cause mortality in hypertensive …

Angiotensin II not only is a vasoconstrictor, but it also affects cell growth and apoptosis,
inflammation, fibrosis, and coagulation. Blockade of the renin-angiotensin system, either …

Objectives To evaluate the blood pressure-dependent and independent effects of
angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) …

Hypertension represents a major common cardiovascular risk factor. Optimal control of high
blood pressure levels is recommended to reduce the global burden of hypertensive …